FQ
SBBP

First Quadrant’s Strongbridge Biopharma plc. SBBP Stock Holding History

First Quadrant’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,100
Closed -$6K – 561
2021
Q3 		$6K Sell
3,100
-5,100
-62% -$11.9K ﹤0.01% 512
2021
Q2 		$24K Sell
8,200
-22,800
-74% -$60.2K ﹤0.01% 476
2021
Q1 		$86K Sell
31,000
-7,982
-20% -$24.1K 0.01% 425
2020
Q4 		$95K Buy
38,982
+14,282
+58% +$34.4K 0.01% 430
2020
Q3 		$52K Sell
24,700
-27,237
-52% -$91.8K 0.01% 486
2020
Q2 		$196K Buy
+51,937
New +$156K 0.03% 431

First Quadrant's SBBP Position: Q4 2021 in Review

First Quadrant sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 3,100 shares — an estimated $6K sold.

First Quadrant first reported a position in SBBP in Q2 2020 and held it in 6 quarters. The position peaked at $196K in Q2 2020. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

  • First Quadrant reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
  • First Quadrant sold 3,100 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $6K.
  • First Quadrant first reported a position in Strongbridge Biopharma plc. in Q2 2020 and held it in 6 quarters.
  • First Quadrant's Strongbridge Biopharma plc. position peaked at $196K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on First Quadrant's 13F filing for Q4 2021, filed 27 Jan 2022.